M&A Deal Summary

Boston Scientific Acquires BridgePoint Medical

On September 19, 2012, Boston Scientific acquired medical products company BridgePoint Medical

Acquisition Highlights
  • This is Boston Scientific’s 15th transaction in the Medical Products sector.
  • This is Boston Scientific’s 18th transaction in the United States.
  • This is Boston Scientific’s 2nd transaction in Minnesota.

M&A Deal Summary
Date 2012-09-19
Target BridgePoint Medical
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition

Target

BridgePoint Medical

Plymouth, Minnesota, United States
website
BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions (CTOs).

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website

Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 22 of 62
Sector (Medical Products) 15 of 48
Type (Add-on Acquisition) 22 of 48
State (Minnesota) 2 of 6
Country (United States) 18 of 47
Year (2012) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-08 Cameron Health

San Clemente, California, United States

Cameron is developing a next generation leadless implantable cardiac defibrillator . Cameron Health company headquartered in San Clemente, California. Founded in 2001, the company has developed the world's first and only commercially available completely subcutaneous ICD (S-ICD System).

Buy $150M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-08 Rhythmia Medical

Burlington, Massachusetts, United States

Rhythmia Medical, Inc. is developing a next generation mapping, visualization and navigation system for the treatment of cardiac arrhythmias. The company is conducting human clinical testing outside the United States and is working with several of the leading clinicians in this field around the world.

Buy $265M
Mergr

Product

Company

Legal